A Case of Cytokine Hemofiltration and Extracorporeal Life Support as Treatment of Coronavirus Disease 2019 (COVID-19) Respiratory Failure
A hyperactive immune response has been implicated in COVID-19 respiratory failure. Hemofiltration with a membrane designed to remove cytokines offers a potential avenue for treatment.
Inter-hospital COVID ECMO Air Transportation
The detailed protocol is described alongside initial data of its use. To date, 14 patients have been placed on ECMO support at an outside facility and successfully transported via helicopter to our hub hospital using this protocol.
Role of Extracorporeal Membrane Oxygenation in Critically Ill COVID-19 Patients and Predictors of Mortality
The present study suggests that ECMO is a potentially lifesaving treatment for selected critically ill COVID‐19 patients. Considering IL‐6 and NT‐per‐BNP, in addition to the RESP score, may enhance outcome predictions.
Hematologic Consequences of the Coronavirus Crisis—Focus on Relevant Clues and Complications for the Perioperative Cardiothoracic and Vascular Community
The purpose of this freestanding editorial is to highlight the hematologic consequences of the COVID-19 pandemic as they provide clues and challenges for the delivery of high-quality patient care.
Preoperative COVID-19 Testing for Cardiovascular Procedures in Endemic Areas Should be Mandatory
It is extremely important for patients, healthcare providers, and the community at large to aggressively test for COVID-19 in the preprocedural period when the infection is endemic.
COVID-19 and ECMO: An Unhappy Marriage of Endothelial Dysfunction and Hemostatic Derangements
It is the authors’ perspective that it is through the integration of diagnostic assessment of viscoelastic testing with dedicated management schemes, up to and including the titration of antifibrinolytic therapies, that unmasks the capacity of this technology to enhance clinical outcomes.
COVID-19 Testing, Surgical Prioritization, and Reactivation in a Congenital Cardiac Surgery Program
In summary, our institutional experience demonstrates that the implementation of universal COVID-19 screening, surgical prioritization, and eventual reactivation is feasible for congenital cardiac surgery programs.
Sublingual Microcirculation in Patients With SARS-Cov-2 Undergoing Veno-Venous Extracorporeal Membrane Oxygenation
Our results showed an altered sublingual microcirculation in patients receiving VV-ECMO for severe SARS-CoV-2 and suggest a potential contribution of endothelia dysfunction to determine microvascular alteration.
Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
Severe patterns of COVID-19 ARDS are characterized by a thrombin burst and the consequent coagulation activation. Mechanisms of fibrinolysis regulation appear unbalanced toward fibrinolysis inhibition. This pattern ameliorates in survivors, whereas it worsens in nonsurvivors.
Acute Type A Aortic Dissection During the COVID-19 Outbreak
We present a case of acute type A aortic dissection in a patient with COVID-19 to highlight the clinical implications of a true emergent procedure during the COVID-19 outbreak.
Early Impact of the COVID-19 Pandemic on Congenital Heart Surgery Programs Across the World: Assessment by a Global Multi-Societal Consortium
We present the results of an international survey sent to pediatric and congenital heart surgeons characterizing the early impact of COVID-19 on the care of patients with CHD.
Severe Acute Proximal Pulmonary Embolism and COVID-19: A Word of Caution
Here we describe the case of a young woman presenting with severe pulmonary embolism, without any associated symptoms of infections.